Jean-Louis Misset
Chairman
Jean-Louis Misset is a full professor of oncology at the University and at the St. Louis Hospital Oncology Division in Paris, France.
Professor Misset has a strong oncology background as an advisor in the field of drug development. As a member of scientific boards and as an advisor Professor Misset has experience of the clinical development of drugs including Topotecan (SmithKlineBeecham), Docetaxel (Aventis), Alimta (Eli Lilly) and Herceptin (Roche).